secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2022-11-21T23:59:59+00:00
Accession:  0001193125-22-289289
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix and SeaSpine name leadership team for combined company; John Bostjancic as CFO
--------------------------------------------------------------------------------

- Merger of equals expected to close Q1 2023, subject to shareholder approvals.
- John Bostjancic (SeaSpine CFO/COO) to serve as CFO of combined company post-closing.
- Keith Valentine (SeaSpine CEO) to be CEO; Jon Serbousek (Orthofix CEO) to be Executive Chairman.
- Full Executive Leadership Team announced, including presidents for orthopedics, spine, biologics, enabling technologies.
- Doug Rice (Orthofix CFO) will assist with integration transition after close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000119312522289289/0001193125-22-289289-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000119312522289289/d407957d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-289289

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer